MedlineMDLN
那斯達克 · USD
39.64
-0.12
(-0.30%)
收盤 11/07 04:59 (UTC+8)
盤後
39.06
39.06
(-1.46%)
11/07 04:59 (UTC+8)
MedlineMDLN
39.64
-0.12
(-0.30%)
財務數據
損益表
- 66.44
- -
- 71.15
- 77.87
- 73.52
- 76.85
- 78.56
- -
- -
- -
- 9.44
- -5.59
- 4.53
- 2.23
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q3 | 2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | |
營業收入淨額 | 7,856,000 | 7,685,000 | 7,352,000 | 7,787,000 | 7,115,000 | - | 6,644,000 |
營業成本 | 5,931,000 | 5,470,000 | 5,511,000 | 5,873,000 | 5,240,000 | - | 4,820,000 |
營業毛利 | 1,925,000 | 2,215,000 | 1,841,000 | 1,914,000 | 1,875,000 | - | 1,824,000 |
營業費用 | 1,425,000 | 1,820,000 | 1,419,000 | 1,489,000 | 1,301,000 | - | 1,253,000 |
研發費用 | - | - | - | - | - | - | - |
推銷及管理費用 | 1,249,000 | 1,643,000 | 1,243,000 | 1,313,000 | 1,124,000 | - | 1,070,000 |
非經常性項目費用 | - | - | - | - | - | - | - |
其他營業費用 | 176,000 | 177,000 | 176,000 | 176,000 | 177,000 | - | 8,000 |
營業利益 | 500,000 | 395,000 | 422,000 | 425,000 | 574,000 | - | 571,000 |
其他收入及費用 | 4,000 | -41,000 | 5,000 | -53,000 | -10,000 | - | - |
利息費用 | 118,000 | 119,000 | 136,000 | 166,000 | 213,000 | 253,000 | 244,000 |
稅前純益 | 386,000 | 235,000 | 291,000 | 206,000 | 345,000 | - | 338,000 |
所得稅 | 68,000 | 96,000 | 52,000 | 26,000 | 23,000 | - | 16,000 |
稅後純益 | 195,000 | 60,000 | 129,000 | 182,000 | 322,000 | - | 322,000 |
基本每股稅後盈餘(元) | 0.23 | 0.07 | 0.16 | -0.01 | 0.18 | 0.42 | 0.18 |
稀釋每股稅後盈餘(元) | 0.22 | 0.07 | 0.16 | -0.01 | - | 0.42 | 0.18 |
基本平均股數(千股) | 876467.00 | 857000.00 | 819000.00 | 810000.00 | 1827634.00 | 799799.00 | 1827634.00 |
稀釋平均股數(千股) | 1316405.00 | 861000.00 | 825000.00 | 810000.00 | 1827634.00 | 799799.00 | 1827634.00 |
還原基本每股稅後盈餘(元) | 0.23 | 0.07 | 0.16 | -0.01 | 0.18 | 0.42 | 0.18 |
還原稀釋每股稅後盈餘(元) | 0.22 | 0.07 | 0.16 | -0.01 | - | 0.42 | 0.18 |
還原基本平均股數(千股) | 876,467 | 857,000 | 819,000 | 810,000 | 1,827,634 | 799,799 | 1,827,634 |
還原稀釋平均股數(千股) | 1,316,405 | 861,000 | 825,000 | 810,000 | 1,827,634 | 799,799 | 1,827,634 |
EBITDA(千元) | 650,000 | 544,000 | 582,000 | 649,000 | 826,000 | 503,000 | 829,000 |